ALT cancer therapeutics (Boehringer Ingelheim/Tessellate Bio)
N/A
Report date: 2025/05/12 11:02:40
NMEFirst In Class
Base Information
Drug NameALT cancer therapeutics (Boehringer Ingelheim/Tessellate Bio)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTessellate BIO BV
China Registration ClassN/A
Develop Information
Active CompaniesTessellate BIO BVBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A